![]() | ![]() |
Formats:
|
||||||||||||||||||
A conserved role of the VEGF pathway in angiogenesis of an ectodermally-derived vasculature 1Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA 2Biology Department, Center for Developmental Biology, and Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA 98195 3Hopkins Marine Station, Department of Biological Sciences, Pacific Grove, CA 93950, USA *Corresponding author: Hopkins Marine Station, 120, Oceanview blvd, Pacific Grove - 93950 CA - USA, Tel: 01 831 655 6206, Fax: 01 831 375 0793, Email: stefanot/at/stanford.edu The publisher's final edited version of this article is available at Dev Biol.Abstract Angiogenesis, the growth and remodeling of a vascular network, is an essential process during development, growth and disease. Here we studied the role of the vascular endothelial growth factor receptor (VEGFR) in experimentally-induced angiogenesis in the colonial ascidian Botryllus schlosseri (Tunicata, Ascidiacea). The circulatory system of B. schlosseri is composed of two distinct, but interconnected regions: a plot of sinuses and lacunae which line the body, and a transparent, macroscopic extracorporeal vascular network. The vessels of the extracorporeal vasculature are morphologically inverted in comparison to the vasculature in vertebrates: they consist of a single layer of ectodermally-derived cells with the basal lamina lining the lumen of the vessel. We found that when the peripheral circulatory system of a colony is surgically removed, it can completely regenerate within 24 to 48 hours and this regeneration is dependent on proper function of the VEGF pathway: siRNA-mediated knockdown of the VEGFR blocked vascular regeneration, and interfered with vascular homeostasis. In addition, a small molecule, the VEGFR kinase inhibitorPTK787/ZK222584, phenocopied the siRNA knockdown in a reversible manner. Despite the disparate germ layer origins and morphology of the vasculature, the developmental program of branching morphogenesis during angiogenesis is controlled by similar molecular mechanisms, suggesting that the function of the VEGF pathway may be co-opted during the regeneration of an ectoderm-derived tubular structure. Keywords: Angiogenesis, Ascidians, Botryllus schlosseri, Tubular Branching, Regeneration, Vascular System, VEGFR INTRODUCTION Development of the vascular system and tubular organs such as the lungs and endocrine glands, involves common elements of cell behavior, such as proliferation, migration and adhesion, which lead to the formation and branching of epithelial tubules (Davies, 2002, 2005). The formation of tubules starts as a simple epithelial pouch from which new branches successively bud, giving rise to a tree-like network of interconnected tubes. Failure of tube formation often leads to organ failure and major disorders (i.e. spina bifida and polycystic kidney disease; Karner et al., 2006). Despite the variability in size, shape, and tissue of origin, these tubular structures are invariably composed of a wrapped epithelium where the apical surface of the cells lines the lumen. In addition, a tube is a universal structure used in both transitory developmental stages as well as in the final morphology of multiple tissues and organs, and can be found throughout many metazoan phyla. Taken together, it might be expected that a canonical genetic pathway controls this conserved process, however, this is not the case: it is known that during vertebrate development tube formation in different tissues is initiated by diverse genetic pathways (reviewed in Lubarsky and Krasnow, 2003, Davies, 2002). In addition, while these vertebrate genes and genetic pathways are conserved and found in multiple phyla, they are not evolutionarily linked to tube formation and can play diverse roles, thus it appears that the genetic control is not fixed (discussed below). One example of this is the control of vascular formation in the vertebrates, where tubular sprouting of mesodermally-derived tissues requires an orchestrated activation of several growth factors. The most important of these occurs via activation of the VEGF (vascular endothelial growth factor) pathway (Cao et al., 2004), which has been established to play a primary role during development of the circulatory system (Tammela et al., 2005; Ferrara et al., 2003). VEGFs show different affinities for specific coupled cell surface tyrosine kinase receptors (Auguste et al., 2005). After binding of the receptor, VEGF initiates a signaling cascade that regulates the proliferation, differentiation and migration of endothelial cells (Tammela et al., 2005; Olsson et al., 2006). In mammals, the three known VEGF receptors (VEGF-R1, VEGF-R2 and VEGF-R3) differ considerably in signaling properties (Tammela et al., 2005), but are all essential for the homeostasis of lymphatic endothelial cells and may also play a role in orchestrating the recruitment of hematopoietic precursors, and the migration of monocytes and macrophages (Holmes and Zachary, 2005). VEGF-like proteins and their receptors evolved relatively early in eumetazoans as indicated by the presence of homologs in several invertebrate phyla, where they seem to be present in a single isoform (Seipel et al., 2004; Tettamanti et al., 2006). Botryllus schlosseri (Subphylum: Tunicata Class: Ascidiacea) is a primitive chordate organism which has a large, experimentally accessible vasculature and represents a new model to study angiogenesis. Ascidians inhabit shallow waters and harbors throughout the world (Kott, 1986) and are considered to be the closest non-vertebrate relatives of vertebrates: an individual begins its life as a tadpole larva, which after a short swimming phase settles to a substratum and metamorphoses into a non-vertebrate body plan (Berrill, 1975). The resulting juvenile, called an oozooid, immediately begins a lifelong, recurring asexual budding process (blastogenesis) which eventually results in a colony of genetically identical individuals, called zooids, (Burighel and Brunetti, 1971; Fig. 1
The circulatory system of Botryllus consists of two vastly different structures. Within each zooid body there is an open circulatory system consisting of an internal plot of sinuses and lacunae of mesenchymal cells which surrounds the major organs and tissues. In addition there is a large extracorporeal vasculature consisting of ramified monolayered vessels running throughout the tunic and ending at the periphery of the colony in sac-like structures called ampullae (Fig. 1 The ampullae (Fig. 1 MATERIALS AND METHODS Animals Botryllus schlosseri colonies were raised at 18-20°C according to Boyd et al. (1986). Clonal replicates were developmentally staged from A to D before the surgery (define “ampullectmy”, see below) according to Watanabe (1953): Genetically identical synchronized systems (groups of zooids sharing a common atrial siphon) were used for the siRNA and drug treatment experiments as well as respective controls. Electron microscopy Colonies at various stages (A-D) were fixed in 1.5% glutaraldehyde in 0.2M sodium cacodylate, pH 7.4, plus 1.6% NaCl. After washing and postfixation in 1% osmium tetroxide (OsO4) in 0.2M sodium cacodylate, specimens were dehydrated and embedded in Epon resin. Sections (60 nm) were stained with uranyl acetate and lead citrate. Micrographs were taken with a Jeol JEM-1230 transmission electron microscope. Vasculature removal and Imaging Peripheral ampullae and parts of the marginal vessels were surgically removed using a wheeler dissection knife (Miltex, PA, USA). All surgical manipulations were performed under a stereomicroscope (Wild Heerbrugg M7A, Gais, Switzerland). The removal of vasculature was visually confirmed by using an inverted microscope (Diaphot 200, Nikon, NY, USA). Time lapse imaging of young colonies (n=7 different colonies, 1-3 zooids each, 1-3 weeks old) was performed by automated microscopy (ImageXpress, Molecular devices Corp., Palo Alto, CA) as described in Voskoboynik et al. (2006). Phase contrast images at varying magnifications were captured for 6 days following the ampullectomy: every 20-60 minutes during the first 4 daysand every 12 hours during the 5thand 6th day. Time lapse imaging of large colonies (n=4 colonies, different genotypes 8-15 zooids each) was performed using a stereomicroscope (Wild Heerbrugg M7A) and a microscope (Diaphot 200, Nikon), coupled to a CCD camera (coolpix995 Nikon). Pictures were taken every 0.5-5 hours during the first 2 days following vasculature removal and once a day thereafter. BsVEGFR cloning and sequencing Two pools of cDNA were synthesized from total RNA extracted from mixed developmental stages (A-D) of fresh B. schlosseri colonies and were screened by nested PCR using degenerate primers designed to amplify the tyrosine kinase domain of VEGF receptors (Christiaen et al., 2002; Tiozzo et al., 2005). A 152bp fragment was used to design homologous primers for 5′ and 3′ RACE. The primers used to amplify BsVEGFR cDNA extremities were as follows: VEGFrace5 5′-tcaacggtagtctcgcctct-3′ and VEGFrace5N 5′-gcctctccgtttctgacgta-3′ (external and nested primer respectively) for 5′-RACE; and VEGFrace3 5′-catctaaaaagtgtattcaccgaga-3′ and VEGFrace3N 5′-agacgtggctgccagaaata-3′ (external and nested primer respectively) for 3′-RACE. Overlapping 5′ and 3′ fragments of approximately 1.7kb and 2.1kb, respectively, were gel purified (Qiaquick gel purification kit, Qiagen), cloned into pGEM-T vector (Promega) and combined with an ori- transprimer donor (GPS-1 Genome Priming System, NEB) for complete sequencing. The putative protein obtained has been analyzed using the Simple Modular Architecture Research Tool (Letunic et al., 2006). Molecular Phylogenetics BsVEGFR nucleotide and amino acid sequences were analyzed with Lasergene (DNAStar). Multiple Alignment of the tyrosine kinase domains was constructed using ClustalW (v. 1.83) algorithm (Thompson et al., 1994) and the distance trees were built using both the neighbor-joining (Saitou and Nei, 1987) and maximum parsimony (data not shown) in MEGA3 (v. 3.1). Bootstrap analysis was carried for each phylogenetic analysis (1,000 interactions; Felsenstein, 1992). Quantitative PCR (q-PCR) For quantitative real time-PCR (q-PCR), systems from a single genotype were collected at different stages (A-D), weighed, flash frozen in liquid nitrogen and maintained at -80°C. RNA was extracted using Nucleospin RNA columns (BD Biosciences Clontech) and reverse transcribed with 200 U of Superscript II (Invitrogen), using a mix of poly-T and random hexamers as primers. Q-PCR was carried out in an iCycler (Bio-Rad) using SYBR Green detection (Bio Rad) with the following BsVEGFR primers: 5′-gaagctttgatggatcgtaagatagcacct-3′ and 5′-agtcataatgcaactcgtttatctcaaagt-3′, which amplified a fragment of 234bp. BsVEGFR expression was normalized to that of alpha-actin as described in Laird et al. (2005). Thermocycling was carried out for 2 minutes at 95°C followed by 43 cycles of 95°C for 30 sec, 58°C for 1 min, and 72°C for 1 min. Analysis of q-PCR was performed using the 2-ΔΔCt method according to Livak and Schmittgen (2001). Each experiment was performed in triplicate, i.e. three different systems from three different genotypes per stage analyzed, and duplicate measurements were reported for each experiment. In situ hybridization (ISH) Whole-mount in situ hybridization was performed with digoxigenin (DIG)-labeled probes as described by Brown and Swalla (2007). Sense and antisense probes were synthesized from PCR products using BsVEGFR clones coding for a 348bp specific region, according to the protocols supplied with the DIG RNA Labelling kit (Roche Molecular Biochemicals). For fluorescent ISH, the samples were photographed with a Leica MZ16-FA dissecting microscope. Alkaline phosphatase (AP) treated samples were embedded in paraplast (Tiozzo et al., 2006) sectioned at various orientations (7-8 μm), cleared from paraplast with xylene, counterstained with 1% Eosin Y, dehydrated and mounted with Eukitt medium (Electronic Microscopy Sciences), and photographed with a Leica light compound microscope. siRNA delivery siRNAs to BsVEGFR were generated using a commercially available kit (Silencer siRNA cocktail kit, Ambion) as previously described (Nyholm et al., 2006). Briefly, B.schlosseri cDNA was amplified with PCR primers modified adding a 20bp T7 region at the 5′ end (5′-taatacgactcactataggggaagctttgatggatcgtaagatagcacct-3′ and 5′-taatacgactcactatagggagtcataatgcaactcgtttatctcaaagt-3′; T7 promoter sequence underlined), which generated a 234bp sequence product. A control dsRNA was created according to Laird et al. 2005. For knockdown experiments, colonies were microinjected into the blood vasculature with 0.5-1.0 μl of siRNA 40-60 μM in B.shlosseri Buffer (25 mM HEPES, 10 mM cysteine, 50 mM EDTA in filtered sea water). Microinjections were repeated once a day between 2 and 7 days, and the injected colonies were subsequently soaked in 250-500 μl of filtered sea water with100pmoles of siRNA. This was repeated for up to 7 days, changing the solution every second day. Ampullaectomy were performed 7 days after the beginning of the treatment (Fig. 3 M
PTK787/ZK222584 treatment PTK787/ZK222584 was kindly provided by Novartis. The powder was dissolved in DMSO to a stock concentration of 100mg/ml and then diluted to working concentrations of 5, 10 and 20μM in DMSO. Each system (5/9 blastozooid each) was microinjected with 0.5-0.9 μl of PTK787/ZK222584, then after 3 hours the peripheral vascular system was dissected and angiogenesis was monitored by microscope. Controls systems were injected with the same volume of DMSO without observing any effect. RESULTS Regeneration of the colonial circulatory system of Botryllus schlosseri We studied vascular regeneration by surgically removing most of the peripheral vasculature consisting of the peripheral ampullae and the colony marginal vessels,- which herein will be called an ampullaectomy. A portion of the peripheral vasculature cannot be removed in our experimental assays, as it is located underneath the individual zooids and is not accessible to manipulation (Fig. 1A
Isolation and characterization of Botryllus schlosseri VEGFR This rapid regeneration suggested that Botryllus represents a novel model to study the molecular mechanisms underlying angiogenesis. To assess conservation of the genetic pathways we isolated the Botryllus schlosseri VEGFR cDNA (BsVEGFR, described in the Methods). A contig of 2926bp coding for a product of 919 amino acid residues was isolated and is closely related to the single VEGFR (Flt1 / Flt4 / Kdr / Pvr) reported in Ciona intestinalis, with an overall amino acid sequence identity of 41%. In the cloned cDNA sequence, the putative extracellular region is characterized by three immunoglobulin like domains, followed by a transmembrane domain and a split tyrosine kinase domain (TK) (Fig. 3 Phylogenetic analysis was done using the conserved TK domains from three families of receptors: VEGFR, fibroblast growth factors (FGFs) and platelet derived growth factors (PDGFs), with the colon carcinoma kinase 4 receptor (PTK7) used as outgroup (Seipel et al., 2004). As shown in Figure 3 B Pattern of expression of BsVEGFR mRNAs As an adult, B.schlosseri has a unique life history which is characterized by constant and synchronized asexual development punctuated by massive turnover of adult individuals via an apoptotic process called takeover (supplemental video 2). This cycle, called blastogenesis, is organized into four stages (A through D; Watanabe, 1953; Fig. 4 A
As described above, the B. schlosseri circulatory system can be subdivided into two distinct segments: that within the zooid body, which consists of sinuses and lacunae, and the extracorporeal vascular system made up of epithelial vessels that connect the zooids and the buds (Fig. 1 BsVEGFR patterns of expression were also studied by fluorescence whole mount in situ hybridization in young colonies (n=15): BsVEGFR transcripts were detected in the epithelial layer of the peripheral ampullae (Fig. 4 B, C Functional analysis of BsVEGFR during vascular regeneration The function of BsVEGFR has been studied by genetic knockdowns using short interfering double stranded RNA (siRNA), delivered by injection and soaking (Laird et al., 2005). In all experiments presented here (a series of 24 independent experiments using different genotypes), BsVEGFR expression was knocked down as shown by RT-PCR analysis (Fig. 5M
Differences between the control and BsVEGFR knockdown experiments were visible 48 hours after the ampullaectomy: the treated systems (n=13) were not capable to initiate angiogenesis, while the controls, injected with either GFP siRNA or Botryllus buffer (see Materials), did not present any evident phenotype (Fig. 5 C, G However, there is a higher order morphological affect of BsVEGFR knockdown. In control colonies, after the takeover phase, the newly developed adult zooids, which were separated by the region where the previous generation was located and had been resorbed, migrated together to form the typical star shaped system (Fig. 5 H, L A recent report suggested that the VEGF pathway may also participate in homeostasis of the vasculature (Lee et al., 2007). To test this, and further assess if the disorganized system phenotype described above was the result of a lack of peripheral vasculature or an effect of BsVEGFR knockdown, similar treatments were performed in colonies where no ampullaectomy had been carried out. Seven systems from two different genotypes were injected and soaked as described previously. Phenotypes were observed and documented on a daily basis and showed no alterations of the blastogenetic cycle, thus BsVEGR did not appear to be required for asexual generation of the zooids. However, after approximately 2 weeks of BsVEGFR knockdown, the circulatory system of the treated colonies began to break down: the vasculature became engulfed with pigmented cells, the epithelia of the peripheral vessels and the ampullae degenerated and became leaky, and blood cells were released into the tunic, which gradually became opaque and lost elasticity, and the blastozooids grew chaotically (Fig. 5 O Specific inhibition of BsVEGFR by PTK787/ZK222584 during angiogenesis PTK787/ZK222584, also known as Vatalanib, is an anilinophthalazine compound and a high affinity inhibitor for the vertebrate VEGF receptors, in particular VEGFR-2/KDR (Wood et al., 2000). It also can inhibit PDGF, Flt-4 and c-Kit receptors, at significantly higher working concentrations (Bold et al., 2000; Hogan and Kolodziej, 2002). As a cultured, marine organism, with rapid regenerative abilities, Botryllus would be a good candidate for chemical screens, and therefore we decided to test this potent VEGF signaling inhibitor. After testing the different concentration (i.e. 5, 10 and 15 μM), eight systems composed of 5-9 blastozooids were microinjected with 0.5-0.9 μl of 20 μM PTK787/ZK222584 in DMSO three hours before (t0-3) the surgical ablation of the peripheral ampullae and the marginal vessel (t0). As shown, a single injection completely inhibited vessel and ampullae regeneration for 120 hours following the surgery (Fig. 6 H
These experiments were also done in colonies where only a portion of the peripheral ampullae and vessels were removed (hemiampullectomy, Fig. 7 B, F
DISCUSSION The colonial ascidians are the closest relative to vertebrates known to use asexual propagation. Every week Botryllus schlosseri regenerates its entire body, including all somatic tissues and the germline (Manni et al., 2007). These regenerative abilities are not limited to this natural process, and will also respond after experimentally-induced injury, (Voskoboynik et al., 2007; Oka and Watababe, 1957; Sabbadin et al., 1975). This regenerative potential makes B. schlosseri a promising model to investigate the molecular basis of regeneration. Vascular regeneration is a dynamic process; therefore we first examined branching morphogenesis of the vasculature by time-lapse microscopy in order to characterize the morphological changes during regeneration, and characterized five distinct stages which occur in both small and large individuals. BsVEGFR in vascular regeneration The B. schlosseri circulatory system is characterized by: (1) open lacunae and sinuses in the body of the zooid, as found in solitary ascidians and most non-vertebrate metazoans, and (2) a peripheral, or colonial, circulatory system composed of vessels which develop via mechanisms comparable to vertebrate angiogenetic sprouting (Burighel and Brunetti, 1971; Gasparini et al., 2007). In order to evaluate the genetic conservation of angiogenesis, we cloned and functionally analyzed the role of the vascular endothelial growth factor receptor (VEGFR) using RNAi-mediated knockdown as well as a mammalian VEGFR inhibitor, PTK787/ZK222584. The VEGF signaling pathway was discovered in vertebrates due to its effects on vascular endothelial cells during vasculogenesis and angiogenesis. However, VEGF and VEGFR homologs have been identified and studied in organisms that lack canonical blood vessels, such as cnidarians (Seipel et al., 2004), annelids (Tettamanti et al., 2003) and arthropods (Duchek et al., 2001). In Drosophila melanogaster the VEGF signaling pathways regulates hematopoiesis and blood cell migration (Heino et al., 2001; Choi et al., 1998) but has not been reported to be involved in typical branching morphogenesis of tubular structures like the tracheal network. In contrast, in the jellyfish Podocoryne carnea, homologs of the VEGF and VEGFR are expressed in the endoderm during the branching of the tentacles and gastrovascular canals (Seipel et al., 2004). In this case, an epithelium interacts with the extracellular matrix and smooth muscle in a process reminiscent of the blood vessel formation in vertebrates, suggesting that the VEGF signaling had an early origin controlling tube formation. Recently, Gasparini et al. (2007) used immunhistochemistry to show the presence of VEGF and VEGFR-1 during tubular sprouting of the vascular vessels during normal blastogenetic cycles of B.schlosseri. Using cross reacting polyclonal antibodies generated to mammalian proteins, they found that co-localization of VEGF and its receptor in the apex of forming vessels as they begin to sprout and elongate, suggesting a role of these angiogenetic factors in the development of the ectodermal vascular network (Gasparini et al., 2007). In this report we confirm the presence of VEGF ligand by partial cloning and characterization of the VEGFR ortholog in B. schlosseri. Given the limits of the procedure, we cannot rule out the possibility that alternative isoforms might be present in Botryllus as in vertebrates (Ferrara et al., 2003; Olsson et al., 2006). However, only one isoform of VEGF receptor has been reported in Ciona intestinalis (Imai et al., 2004), and in Botryllus a number of RACE and RT-PCR experiments from the conserved kinase domain only resulted in a single gene. Moreover, analysis of a 32,000 clone EST library recently completed revealed only the single VEGR gene (unpublished). The phylogenetic comparisons (Fig. 3B Quantification by qPCR of the mRNA transcripts showed a uniform presence of BsVEGFR throughout the colonial blastogenic stages with significantly higher expression in the external ampullae and blood vessels when compared with the rest of the colony (Fig. 4 A The Botryllus external vasculature is a dynamic tissue that remodels itself according to the stage of the system with a well-defined and consistent pattern, suggesting an essential developmental role in the colony during asexual propagation (Burighel and Brunetti, 1971). After takeover, the zooids are spatially distant from one another, but within a few hours they migrate and cluster, reconstituting the classical star shaped feature (supplemental video 2). Depletion of the ampullae and the peripheral vessels via ampullaectomy, BsVEGFR knockdown affected the organization of the newly developed zooids in the colony without altering the morphogenesis of the zooid itself, suggesting that the extracorporeal vasculature provides spatial information to mechanically drive and/or orient the zooids after each blastogenetic cycle, dictating the shape of the colony. The contribution of blood vessels to morphogenesis is not surprising; analogous interactions have been shown to occur during organogenesis of the pancreas (Lammert et al., 2001) and in the development of the liver (Matsumoto et al., 2001). We observed that the prolonged inhibition of BsVEGFR expression in surgically unaltered colonies produced a clear perturbation of the integrity of the vessels and the ampullae, suggesting an effect on the homeostasis of the vascular system (Fig. 5 N, O PTK787/ZK222584 phenocopies functional loss of BsVEGFR PTK787/ZK 222584 (1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine succinate) is a potent inhibitor of all human vascular endothelial growth factor (VEGF) receptor tyrosine kinases, and active in a submicromolar range. The specificity of PTK787/ZK222584 across species boundaries has previously been tested in vivo and in vitro in non mammalian models like zebrafish (Chan et al., 2002; Lee et al., 2006) but never in non-vertebrate chordates. Given the level of overall homology (49% amino acid identity) between the BsVEGFR tyrosine kinase domain and the human counterpart and the potential ease of doing high throughput chemical screens in B.schlosseri during regeneration, we did a proof-of-principle experiment using this compound. After calibrating the minimal effective dose (20μM), we observed that the PTK787/ZK222584-treated colonies responded in an identical manner to short-term VEGFR knockdown, including affects on regeneration and homeostasis. However, due to the fact that the drug had to be dissolved in DMSO, we could not perform long-term PTK treatments as repeated injection of the solvent adversely affected the colony. BsVEGFR in vascular regeneration: homologies and analogies Mammalian endothelial vasculogenesis and angiogenesis are morphologically analogous to ectodermal sprouting, for example morphogenesis of the tracheas in Drosophila melanogaster (Ghabrial and Krasnow, 2006; Myat, 2005) or development of mammary glands in mammals (Mailleux et al., 2002;.Radisky et al., 2003). In both cases, these processes lead to the formation of tubular structures. To our knowledge, VEGF has not been shown to play a role in ectodermally derived, tubular structures in other organisms, and to our knowledge this is the first report of VEGF pathway involvement in development of ectodermally-derived epithelia. However, these features suggest that, despite the conserved machinery that seems to control the morphogenetic events that lead to tubular structures in divergent animal clades, i.e. vertebrates, insects and tunicates, the tubular branching program may have been reinvented many times. As discussed above, the peripheral vasculature of B.schlosseri has two peculiar dissimilarities with the vertebrates: the inverted basal-apical polarity of vessel epithelia, and its ectodermal origin. In this context the data suggests that VEGF signaling may not function directly upstream of the establishment of cell polarity in the epithelia during angiogenesis, nor is it restricted to stimulation of cells of similar ontogenetic origin. Conclusions Formation of branching tubular epithelia is a common process in metazoan organogenesis, where tubular systems regenerate using strategies that are based on common elements of cell behavior and variations of genetic pathways (Davies, 2002; Hogan and Kolodziej, 2002). Here we take advantage of the high regenerative potential of the extracorporeal vascular system of Botryllus schlosseri to investigate the functional role of the VEGF pathway, a key component of vertebrate angiogenesis. While the cellular organization and embryonic germ layer origin in the Botryllus tubular network is different than that of the vertebrate vasculature, both molecular and chemical approaches established a conserved function of the VEGF pathway, which controls the tubular branching in the ectodermally-derived Botryllus vascular epithelia. The rapid regeneration, transparency and experimental accessibility of the B. schlosseri extracorporeal vasculature make it a potentially insightful model for in vivo studies of angiogenesis using both reverse genetic and chemical screening approaches. 01 Supplemental video 1: Botryllus schlosseri vasculature regeneration following ampullaectomy. Time laps images were taken every 30 minutes for a period of 30 hours following ampullae removal. Amp: ampullae, bv: blood vessel, numbers regeneration spots, t: time, h; hours. Click here to view.(9.4M, avi) 02 Supplemental video 2: Botryllus schlosseri young generation takes over its parents place. In these time lapse images, we followed the synchronous death (mainly via apoptosis) of the parent zooids (during blastogenesis stage D) and its replacement by the asexually derived buds of the next generation. Time lapse images were taken every 30 minutes during a period of 27 hours. res. Zooid: resorbing zooid, sb: secondary bud, bv: blood vessel. Click here to view.(17M, avi) ACKNOWLEDGEMENTS We thank Kathi Ishizuka, Karla Palmeri and Randy Will for technical support and Billie Swalla, Ulrich Kurn and Michelle Roux for their comments on the manuscripts. The research was supported by NIH (RO1A104588/R01DK405762), the Stanford School of Medicine Dean’s fellowship to ST, the Lerner Gray Fund for Marine Research and the American Heart Association Fellowship Grant to FDB. Footnotes Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. REFERENCES
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Bioessays. 2002 Oct; 24(10):937-48.
[Bioessays. 2002]Curr Opin Genet Dev. 2005 Aug; 15(4):364-70.
[Curr Opin Genet Dev. 2005]Semin Cell Dev Biol. 2006 Apr; 17(2):214-22.
[Semin Cell Dev Biol. 2006]Cell. 2003 Jan 10; 112(1):19-28.
[Cell. 2003]Circ Res. 2004 Mar 19; 94(5):664-70.
[Circ Res. 2004]Cardiovasc Res. 2005 Feb 15; 65(3):550-63.
[Cardiovasc Res. 2005]Nat Med. 2003 Jun; 9(6):669-76.
[Nat Med. 2003]Crit Rev Oncol Hematol. 2005 Apr; 54(1):53-61.
[Crit Rev Oncol Hematol. 2005]Nat Rev Mol Cell Biol. 2006 May; 7(5):359-71.
[Nat Rev Mol Cell Biol. 2006]Dev Dyn. 2007 Feb; 236(2):335-52.
[Dev Dyn. 2007]Tissue Cell. 2006 Jun; 38(3):193-201.
[Tissue Cell. 2006]Proc Natl Acad Sci U S A. 2004 Jan 27; 101(4):986-91.
[Proc Natl Acad Sci U S A. 2004]Dev Genes Evol. 2004 Feb; 214(2):81-8.
[Dev Genes Evol. 2004]Dev Dyn. 2007 Mar; 236(3):719-31.
[Dev Dyn. 2007]Cell. 2003 Jan 10; 112(1):19-28.
[Cell. 2003]Nature. 2005 Nov 24; 438(7067):454-9.
[Nature. 2005]Immunity. 2006 Jul; 25(1):163-73.
[Immunity. 2006]Dev Dyn. 2005 Dec; 234(4):997-1005.
[Dev Dyn. 2005]Gene. 2002 Apr 3; 287(1-2):107-13.
[Gene. 2002]Dev Dyn. 2005 Feb; 232(2):468-78.
[Dev Dyn. 2005]Nucleic Acids Res. 2006 Jan 1; 34(Database issue):D257-60.
[Nucleic Acids Res. 2006]Nucleic Acids Res. 1994 Nov 11; 22(22):4673-80.
[Nucleic Acids Res. 1994]Mol Biol Evol. 1987 Jul; 4(4):406-25.
[Mol Biol Evol. 1987]Genet Res. 1992 Dec; 60(3):209-20.
[Genet Res. 1992]Dev Dyn. 2005 Dec; 234(4):997-1005.
[Dev Dyn. 2005]Methods. 2001 Dec; 25(4):402-8.
[Methods. 2001]Evol Dev. 2007 Mar-Apr; 9(2):165-77.
[Evol Dev. 2007]Tissue Cell. 2006 Jun; 38(3):193-201.
[Tissue Cell. 2006]Immunity. 2006 Jul; 25(1):163-73.
[Immunity. 2006]Dev Dyn. 2005 Dec; 234(4):997-1005.
[Dev Dyn. 2005]Dev Dyn. 2004 Oct; 231(2):303-12.
[Dev Dyn. 2004]Cell Tissue Res. 1993 Apr; 272(1):115-27.
[Cell Tissue Res. 1993]Dev Dyn. 1992 May; 194(1):71-83.
[Dev Dyn. 1992]Dev Dyn. 2005 Dec; 234(4):997-1005.
[Dev Dyn. 2005]Cell. 2007 Aug 24; 130(4):691-703.
[Cell. 2007]Cancer Res. 2000 Apr 15; 60(8):2178-89.
[Cancer Res. 2000]J Med Chem. 2000 Aug 10; 43(16):3200.
[J Med Chem. 2000]Nat Rev Genet. 2002 Jul; 3(7):513-23.
[Nat Rev Genet. 2002]Dev Dyn. 2007 Feb; 236(2):335-52.
[Dev Dyn. 2007]FASEB J. 2007 May; 21(7):1335-44.
[FASEB J. 2007]Dev Biol. 1975 Sep; 46(1):79-87.
[Dev Biol. 1975]Dev Dyn. 2007 Mar; 236(3):719-31.
[Dev Dyn. 2007]Dev Dyn. 2004 Oct; 231(2):303-12.
[Dev Dyn. 2004]Cell. 2001 Oct 5; 107(1):17-26.
[Cell. 2001]Mech Dev. 2001 Nov; 109(1):69-77.
[Mech Dev. 2001]Development. 1998 Feb; 125(4):725-32.
[Development. 1998]Nat Med. 2003 Jun; 9(6):669-76.
[Nat Med. 2003]Nat Rev Mol Cell Biol. 2006 May; 7(5):359-71.
[Nat Rev Mol Cell Biol. 2006]Development. 2004 Aug; 131(16):4047-58.
[Development. 2004]Science. 2001 Oct 19; 294(5542):564-7.
[Science. 2001]Science. 2001 Oct 19; 294(5542):559-63.
[Science. 2001]Cell. 2007 Aug 24; 130(4):691-703.
[Cell. 2007]Dev Dyn. 2007 Mar; 236(3):719-31.
[Dev Dyn. 2007]Cancer Cell. 2002 Apr; 1(3):257-67.
[Cancer Cell. 2002]Dev Dyn. 2006 Jan; 235(1):29-37.
[Dev Dyn. 2006]Nature. 2006 Jun 8; 441(7094):746-9.
[Nature. 2006]Dev Dyn. 2005 Mar; 232(3):617-32.
[Dev Dyn. 2005]Development. 2002 Jan; 129(1):53-60.
[Development. 2002]Trends Cell Biol. 2003 Aug; 13(8):426-34.
[Trends Cell Biol. 2003]Bioessays. 2002 Oct; 24(10):937-48.
[Bioessays. 2002]Nat Rev Genet. 2002 Jul; 3(7):513-23.
[Nat Rev Genet. 2002]